Intelligent Bio Solutions Inc.
INBS
$0.66
-$0.01-1.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.46% | 15.95% | -11.52% | -20.49% | 9.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.46% | 15.95% | -11.52% | -20.49% | 9.57% |
| Cost of Revenue | 12.94% | 679.59% | -39.95% | -31.94% | -6.79% |
| Gross Profit | 49.45% | -58.85% | 91.26% | 12.00% | 49.29% |
| SG&A Expenses | 36.47% | 1.78% | -0.75% | 6.11% | -20.68% |
| Depreciation & Amortization | 1.00% | 5.55% | -5.30% | 5.13% | -2.34% |
| Other Operating Expenses | -53.29% | -392.81% | -106.80% | 12.79% | -14.74% |
| Total Operating Expenses | 7.01% | 5.25% | -13.11% | 4.23% | 8.28% |
| Operating Income | -0.46% | -2.49% | 13.56% | -13.71% | -7.87% |
| Income Before Tax | -11.14% | -10.99% | 14.60% | -14.19% | -10.79% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.14% | -10.99% | 14.60% | -14.19% | -10.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 30.43% | 12.61% | -21.98% | 8.96% | 27.78% |
| Net Income | -11.07% | -10.99% | 14.58% | -14.21% | -10.74% |
| EBIT | -0.46% | -2.49% | 13.56% | -13.71% | -7.87% |
| EBITDA | 0.15% | -2.08% | 13.80% | -14.63% | -8.99% |
| EPS Basic | 50.48% | 51.79% | 69.22% | 76.09% | 94.36% |
| Normalized Basic EPS | 54.84% | 55.23% | 69.21% | 76.08% | 94.36% |
| EPS Diluted | 50.48% | 51.87% | 69.22% | 76.09% | 94.36% |
| Normalized Diluted EPS | 54.84% | 55.23% | 69.21% | 76.08% | 94.36% |
| Average Basic Shares Outstanding | 124.26% | 130.18% | 177.51% | 377.60% | 1,862.46% |
| Average Diluted Shares Outstanding | 124.26% | 130.18% | 177.51% | 377.60% | 1,862.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |